You need to enable JavaScript to run this app.
Asia-Pacific Roundup: Singapore’s HSA gives industry a year to comply with new drug substance evidence requirements
Roundups
Nick Paul Taylor
Asia
Chemistry, Manufacturing and Controls (CMC)
Oceania
Pharmaceuticals